Archives
-
SUMO Protease (Ulp): Product Overview
2026-10-08
SUMO Protease (Ulp) is described by APExBIO as a recombinant yeast Ulp1-derived cysteine protease intended for SUMO fusion tag cleavage. No matched paper evidence was provided, so performance claims remain supplier-reported.
-
0.4% Trypan Blue Solution Overview
2026-10-08
A concise, source-limited overview of APExBIO’s K1183 0.4% Trypan Blue Solution, covering its documented identity, conceptual research scope, and evidence limitations.
-
PDAC Organoid–Fibroblast Models of Chemoresistance
2026-10-07
Schuth et al. developed patient-matched three-dimensional pancreatic ductal adenocarcinoma organoid–fibroblast co-cultures to examine how stromal cells alter chemotherapy response. Their findings associate cancer-associated fibroblasts with increased organoid proliferation, reduced treatment-related cell death, inflammatory fibroblast states, and epithelial-to-mesenchymal transition programs, while also defining important limits for interpretation and clinical translation.
-
Engineered Klotho mRNA Reverses Cellular Senescence
2026-10-07
A 2026 study reports that hyperbranched poly(β-amino ester)s can deliver engineered Klotho mRNA to aged and Klotho-deficient induced mesenchymal stem cells, restoring Klotho expression and several markers of cellular homeostasis. The findings support a non-integrating, transcript-based strategy for studying senescence, while remaining limited to cellular models and requiring validation beyond the reported in vitro system.
-
Protease Inhibitor Cocktails in Plant Symbiosis Research
2026-10-06
A source-grounded overview of how protein preservation relates to research on flavonoid regulation and plant–microbe symbiosis. The 2026 Current Biology study identifies an NSP2–MYB40 regulatory module in Medicago truncatula, while the APExBIO Protease Inhibitor Cocktail is discussed only as a conceptual tool for protecting extracted proteins; the supplied sources do not establish that the product was used in, or validated by, that study.
-
hsa_circ_0136666 and Gastric Cancer Immune Escape
2026-10-05
Miao et al. identify hsa_circ_0136666 as an oncogenic circular RNA that links the miR-375/PRKDC axis to PD-L1 phosphorylation and CD8+ T-cell suppression in gastric cancer. The study combines clinical tissue analysis, cell-based mechanistic assays, and tumor models to suggest that silencing this circRNA may improve anti-PD-L1 responses, while remaining a preclinical finding that requires further validation.
-
Cy5 Amine (Non-Sulfonated): Product Overview
2026-10-05
Cy5 amine (non-sulfonated), SKU A8143, is a supplier-described amine-functionalized cyanine dye for research labeling concepts. No matched paper evidence was provided, so its specifications and application scope are not independently validated here.
-
Duplex ddPCR for Long Self-Amplifying RNA
2026-10-04
Casmil, Huang, and Blakney developed a duplex droplet digital PCR strategy for absolute quantification and integrity assessment of long self-amplifying RNA. Their results show that reverse-transcription format materially affects estimated transcript abundance, while simultaneous measurement of genomic and subgenomic RNA reveals strong intracellular amplification dynamics.
-
Hexose Diphosphate: Metabolism to Inflammation
2026-10-01
Hexose diphosphate is a water-compatible metabolic intermediate for studying glycolytic control, ischemic energy balance, and carbohydrate-dependent signaling. This article explains how to interpret hexose phosphate perturbations alongside new evidence that the distinct metabolite PEP can regulate cGAS–STING inflammation.
-
DNase I (RNase-free) for RNA Workflow Control
2026-10-01
Improve RNA extraction, IVT cleanup, and RT-PCR specificity with a cation-dependent nuclease designed to remove DNA without introducing RNase activity. Pair targeted DNA digestion with duplex ddPCR to distinguish cleaner samples from genuinely intact long RNA.
-
SUMO Protease (Ulp): Practical Cleavage Guide
2026-09-30
SUMO Protease (Ulp) removes SUMO fusion tags by cleaving immediately downstream of the SUMO C-terminal Gly-Gly motif, supporting affinity purification and downstream protein analysis. It is intended for SUMO-tagged recombinant proteins and should not be used as a universal tag-removal enzyme or general protein degradation reagent.
-
GI Device Delivery of mRNA-LNPs in Mice and Pigs
2026-09-29
Schultz and colleagues investigated whether ingestible microjet devices could deliver mRNA–lipid nanoparticles into the gastric or intestinal wall and generate systemic expression. Their mouse and minipig data show route-dependent expression and biodistribution, supporting gastrointestinal wall injection as a preclinical alternative to conventional parenteral administration while leaving clinical efficacy and safety to be established.
-
X-press Tag Peptide: Purification Workflow Guide
2026-09-29
Use the X-press Tag Peptide to combine polyhistidine capture, Anti-Xpress antibody detection, and enterokinase release in one N-terminal design. This practical guide connects reproducible recombinant-protein purification with assay planning for RHEB signaling and post-translational-modification studies.
-
CAF Lactate and Oxaliplatin Resistance in CRC
2026-09-28
The reference study identifies a stromal mechanism of oxaliplatin resistance in colorectal cancer: glycolytic cancer-associated fibroblasts supply lactate that drives ANTXR1 transcription and ANTXR1 K453 lactylation. By connecting lactate signaling with cancer stemness through the RhoC/ROCK1/SMAD5 pathway, the work provides a mechanistic rationale for targeting tumor–stromal metabolic communication.
-
Actinomycin D in Vascular mRNA Stability Research
2026-09-28
Actinomycin D (ActD) can help distinguish changes in mRNA production from changes in transcript decay. This article connects transcriptional inhibition to a recent NF90–FBXW7–AGER1 study of diabetic vascular calcification and explains how to interpret the assay without mistaking a broad inhibitor for a pathway-specific probe.